Interventions for lowering plasma homocysteine levels in dialysis patients

Sagar U Nigwekar; Amy Kang; Sophia Zoungas; Alan Cass; Martin P Gallagher; Satyarth Kulshrestha; Sankar D Navaneethan; Vlado Perkovic; Giovanni FM Strippoli; Meg J Jardine

doi:10.1002/14651858.CD004683.pub4

Scolaris Content Display Scolaris Content Display

Contenido relacionado

Ir a:

Revisiones y protocolos relacionados
Respuestas clínicas Cochrane
Guías
Temas

Revisiones y protocolos relacionados

Respuestas clínicas Cochrane

Topics

Temas

Figure 1

Flow diagram showing study selection

Ir a la figura de la revisiónAbrir en una pestaña nueva

Figure 2

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Figure 3

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Figure 4

Funnel plot of comparison: 2 Secondary outcomes, outcome: 2.1 all‐cause mortality

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 1.1

Comparison 1 Primary outcome, Outcome 1 Cardiovascular mortality.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 2.1

Comparison 2 Secondary outcomes, Outcome 1 All‐cause mortality.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 2.2

Comparison 2 Secondary outcomes, Outcome 2 Myocardial infarction (fatal and non fatal).

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 2.3

Comparison 2 Secondary outcomes, Outcome 3 Coronary revascularisation.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 2.4

Comparison 2 Secondary outcomes, Outcome 4 Stroke.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 2.5

Comparison 2 Secondary outcomes, Outcome 5 Deep venous thrombosis and pulmonary embolism.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 2.6

Comparison 2 Secondary outcomes, Outcome 6 Thrombosis of dialysis access.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 2.7

Comparison 2 Secondary outcomes, Outcome 7 Adverse events.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Comparison 1. Primary outcome

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Cardiovascular mortality Show forest plot	4	1186	Risk Ratio (M‐H, Random, 95% CI)	0.93 [0.70, 1.22]

Comparison 1. Primary outcome

Ir a la tabla de la revisión

Comparison 2. Secondary outcomes

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 All‐cause mortality Show forest plot	6	2447	Risk Ratio (M‐H, Random, 95% CI)	1.00 [0.89, 1.11]

2 Myocardial infarction (fatal and non fatal) Show forest plot	4	1510	Risk Ratio (M‐H, Random, 95% CI)	1.04 [0.66, 1.62]

3 Coronary revascularisation Show forest plot	2	1160	Risk Ratio (M‐H, Random, 95% CI)	0.83 [0.22, 3.14]

4 Stroke Show forest plot	4	1510	Risk Ratio (M‐H, Random, 95% CI)	0.89 [0.57, 1.40]

5 Deep venous thrombosis and pulmonary embolism Show forest plot	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected

6 Thrombosis of dialysis access Show forest plot	2	1261	Risk Ratio (M‐H, Random, 95% CI)	1.00 [0.88, 1.14]

7 Adverse events Show forest plot	3	1248	Risk Ratio (M‐H, Random, 95% CI)	1.12 [0.51, 2.47]

Comparison 2. Secondary outcomes

Ir a la tabla de la revisión

The Cochrane Library

Scolaris Language Selector Scolaris Language Selector

Idioma de la Revisión Cochrane

Idioma de la web

Scolaris Content Language Banner Portlet Scolaris Content Language Banner Portlet